Last updated: February 27, 2025
Sponsor: Johns Hopkins University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hiv
Lung Disease
Treatment
Active TB case finding with linkage to preventive therapy (ACF/TPT)
Clinical Study ID
NCT05285202
IRB00300939
2R01HL138728
Ages > 5 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥15 years, OR age 5-14 and a close contact of someone diagnosed with TB,
Provision of oral informed consent, or, if age <18 years and not legallyemancipated, oral informed assent (if ages 8-17) and parental informed consent (ages 5-17) to participate in the study
Ability to communicate with study staff in English or Luganda, or availability of acapable interpreter who is acceptable to the participant
Exclusion
Exclusion Criteria:
- On treatment for, or diagnosed with but not yet treated for, active TB
Study Design
Total Participants: 150000
Treatment Group(s): 1
Primary Treatment: Active TB case finding with linkage to preventive therapy (ACF/TPT)
Phase:
Study Start date:
June 01, 2022
Estimated Completion Date:
January 31, 2027
Connect with a study center
Walimu
Kampala,
UgandaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.